BioLife Solutions, Inc. (BLFS)
24.92
+0.04
(+0.16%)
USD |
NASDAQ |
Dec 12, 11:19
BioLife Solutions Cash from Investing (Quarterly): -5.967M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| INVO Fertility, Inc. | -0.0081M |
| NeuroOne Medical Technologies Corp. | -0.0435M |
| SINTX Technologies, Inc. | 0.666M |
| Nutriband, Inc. | 0.00 |
| enVVeno Medical Corp. | 3.651M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.104M |
| Cash from Financing (Quarterly) | -2.558M |
| Free Cash Flow | 10.56M |
| Free Cash Flow Per Share (Quarterly) | 0.0575 |
| Free Cash Flow to Equity (Quarterly) | 5.94M |
| Free Cash Flow to Firm (Quarterly) | 2.802M |
| Free Cash Flow Yield | 0.88% |